New Delhi: Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs. 510 crores) from its distribution centres in the U.S, Europe and Asia that have been identified as part of India’s Covid-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on Monday.
In his linked post Bourla said, “We are deeply concerned by the critical Covid-19 situation in India and our hearts go out to you, your loved ones and all the people of India.”
Further, Bourla said, “We are donating these medicines to help make sure that every covid-19 patient in every public hospital across the country can have access to the Pfizer medicines they need free of charge.”
Right now, Pfizer colleagues at distribution centres in the US, Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its Covid-19 treatment protocol, Bourla added. Bourla added that these medicines, which valued more than USD 70 million, will be made available immediately and will work closely with the government and our NGO partners to get them to where they are needed most